TI
RVMD icon

Trexquant Investment’s Revolution Medicines RVMD Stock Holding History

Trexquant Investment’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22.5M Buy
120,122
+51,513
+75% +$7.52M 0.13% 162
2026
Q1 		$6.67M Buy
68,609
+36,146
+111% +$3.65M 0.05% 539
2025
Q4 		$2.59M Sell
32,463
-131,250
-80% -$8.61M 0.02% 891
2025
Q3 		$7.65M Sell
163,713
-89,622
-35% -$3.51M 0.08% 386
2025
Q2 		$9.32M Buy
253,335
+194,121
+328% +$7.46M 0.11% 271
2025
Q1 		$2.09M Buy
+59,214
New +$2.4M 0.02% 853
2023
Q3 		– Sell
-52,181
Closed -$1.4M – 1771
2023
Q2 		$1.4M Buy
+52,181
New +$1.28M 0.04% 635
2022
Q3 		– Sell
-25,212
Closed -$491K – 1776
2022
Q2 		$491K Buy
25,212
+15,885
+170% +$309K 0.02% 835
2022
Q1 		$238K Sell
9,327
-10,073
-52% -$219K 0.01% 1125
2021
Q4 		$488K Buy
+19,400
New +$547K 0.03% 652
2021
Q3 		– Sell
-10,089
Closed -$320K – 1436
2021
Q2 		$320K Buy
10,089
+1,650
+20% +$57.6K 0.03% 681
2021
Q1 		$387K Buy
+8,439
New +$378K 0.04% 628

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Trexquant Investment's RVMD Position: Q2 2026 in Review

Trexquant Investment increased its Revolution Medicines (RVMD) stake by 75% in Q2 2026, buying an estimated $7.52M and bringing the position to 120,122 shares worth $22.5M. The position accounts for 0.13% of the portfolio, ranked #162.

Trexquant Investment first reported a position in RVMD in Q1 2021 and has held it in 12 quarters since. 691 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Trexquant Investment held 120,122 shares of Revolution Medicines worth $22.5M as of Q2 2026.
  • Trexquant Investment bought 51,513 Revolution Medicines shares in Q2 2026, an estimated $7.52M.
  • Revolution Medicines made up 0.13% of Trexquant Investment's portfolio in Q2 2026, its #162 holding.
  • Trexquant Investment first reported a position in Revolution Medicines in Q1 2021 and has held it in 12 quarters since.
  • 691 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.